The poor third-quarter profit led the company to revise its yearly outlook. Walgreens cut its full-year earnings outlook to between $4 and $4.05 a share from $4.45 and $4.65 a share.
The decision reflects less demand for COVID-19 tests and vaccines and a murky macroeconomic outlook.
Despite the falling profits, Walgreens reported an 8.6 percent jump in year-over-year sales, according to a June 27 Walgreens news release.
“Our revised guidance takes an appropriately cautious forward view in light of consumer spending uncertainty, while still demonstrating clear drivers of a return to operating growth next fiscal year. We are raising our cost savings program target to $4.1 billion and taking immediate actions to optimize profitability for our U.S. healthcare segment,” Walgreens Boots Alliance CEO Rosalind Brewer said in the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
